CvilleBioHub is seeking an engaged and motivated Program Manager to drive growth of the organization and to promote the biotechnology sector in our region.
Press Release: CvilleBioHub Awarded $80,000 GO Virginia Grant To Accelerate and Sustain Regional Life Sciences Industry Growth
The CvilleBioHub has been awarded over $80,000 from the GO Virginia initiative to expand and sustain the life sciences ecosystem in the region. The grant will enable the two-year-old organization to develop a long-term strategic plan to increase the number of local biotechnology companies, attract top executive and scientific talent to existing companies and engage with stakeholders to increase awareness of opportunities in the region.
The Tom Sox have been a part of summers in Charlottesvilles since 2015 when they kicked off their inaugural season at Charlottesville High School. This year HemoShear Therapeutics has added two Tom Sox pitchers to their team as interns.
Our First Partnership! AMPEL Biosolutions and ArcheMedX join forces in a strategic partnership to improve the success rate of clinical trials. This partnership builds on AMPEL’s expertise in clinical operations and ArcheMedX digital platform for online healthcare education to improve patient recruitment and attention.
3rd Annual Spring Biosciences Lunch - Diffusion’s Story: How to Create a $100MM Biopharma Company in Central VA with David Kalergis, CEO
Diffusion’s Story is about strategy, leveraging capital, keeping investors happy, getting the science right and overcoming the challenges of bringing modern medicines to market. Local investor capital, a cool $25MM, raised here in Charlottesville, was key to Diffusion’s success.
At the luncheon, there will be a TV style interactive discussion about ‘Diffusion’s Story” and more.
Bonumose has just filed a patent for low cost manufacture of plant based galactose using its innovative enzymatic technology platform. Dan Wicheleski will be speaking about these latest developments at the Tom Tom Founders Summit Biotechnology Luncheon, Friday April 14.
AMPEL BioSolutions and ArcheMedX Form Partnership Aimed at Improving Success Rate of Clinical Trials
AMPEL BioSolutions, a leading translational medicine and clinical operations company and ArcheMedX, a digital platform for effective online health care education and training programs, today announced a new collaboration to transform clinical trial recruitment and retention by enabling research sites to more effectively educate and continually engage clinical staff and patients.